Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy.
Lin RY, Anderson AD, Natori Y, Raja M, Morris MI, Jimenez AJ, Beitinjaneh A, Wang T, Goodman M, Lekakis L, Spiegel J, Holtzman NG, Pereira D, Benjamin C, Natori A, Komanduri KV, Camargo JF.
Lin RY, et al.
Blood Adv. 2024 Jul 23;8(14):3813-3822. doi: 10.1182/bloodadvances.2024012922.
Blood Adv. 2024.
PMID: 38838226
Free PMC article.